Background: This prospective case series report aimed at analyzing the long-term (5 years) stability of clinical attachment level (CAL) gains following regenerative therapy with the use of enamel matrix proteins in intrabony defects.
Methods: A total of 114 consecutively treated periodontal patients (mean age: 55.8 years) were initially included. Each subject exhibited at least one deep proximal intrabony defect with the inclusion criteria of 1) probing depth (PD) ‡5 mm, 2) clinical attachment loss ‡6 mm, and 3) radiographic evidence of a ‡3-mm intrabony component. A total of 146 defects met the criteria for inclusion. At least 6 months after the completion of an initial phase of mechanical infection control, a baseline examination was performed to characterize the experimental site. Reconstructive therapy with the use of enamel matrix proteins was subsequently performed. Experimental sites were reexamined 1 and 5 years after reconstructive surgery. Primary efficacy variables were considered to be changes in PD, CAL, soft tissue recession (REC), and radiographic defect depth (RDD). Stepwise regression analysis was employed for evaluation of predicting factors of CAL change between the 1-and 5-year reexaminations.
Results: A total of 82 patients (102 defects) were included in the analysis. One year following the regenerative surgery, a mean CAL gain of 4.3 mm ( P <0.001), a mean PD reduction of 4.9 mm ( P <0.001), and a mean increase in REC of 0.6 mm ( P <0.001) were recorded. At the 5-year follow-up, a further mean PD reduction of 0.3 mm ( P >0.05), CAL gain of 1.1 mm ( P <0.01), and reduction in recession of 0.8 mm ( P <0.01) had taken place. Radiographs revealed that the bone defect had been reduced in depth with an average of 2.9 mm at 1 year ( P <0.001). No statistically significant alteration in defect depth was observed between 1 and 5 years of follow-up. The stepwise regression analysis identified the degree of REC and residual PD at 1 year as significant predictors of CAL change between 1 and 5 years.
Conclusion: Results demonstrated long-term (5 years) stability of CAL gains following regenerative therapy with the use of enamel matrix proteins in intrabony defects. J Periodontol 2006;77:295-301.
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I n conjunction with surgical periodontal therapy, various devices (e.g., barrier membranes and filler materials) and biologic mediators (e.g., growth factors and extracellular matrix proteins) frequently are used in attempts to enhance treatment outcomes. [1] [2] [3] [4] [5] The first randomized clinical trial on the use of extracellular matrix proteins (enamel matrix derivative [EMD]) was published by Heijl et al. 6 and described a 3-year placebo-controlled multicenter trial that involved 33 patients with paired intrabony defects of predominantly 2-and 1-wall morphology. Follow-up examinations performed 8 and 36 months after treatment revealed a mean gain of clinical attachment level (CAL) of 2.1 and 2.2 mm, respectively, for the test sites, and 1.5 and 1.7 mm, respectively, for the control sites. Radiographs of bone alterations showed that the EMD treatment resulted in a mean 2.7-mm gain of bone height, whereas at control sites, only minor and insignificant changes were observed at the 3-year follow-up examination.
More recently, two multicenter randomized controlled studies were reported. 7, 8 In the study by Tonetti et al., 7 172 patients at 12 centers in seven countries were evaluated 1 year after treatment with either open flap debridement (OFD) combined with EMD or OFD only. The multivariate analysis displayed that EMD, in comparison to OFD treatment, provided a statistically significant additional mean CAL gain of 0.5 mm. There was, however, a substantial degree of variability in treatment outcome. Thus, a pronounced center effect was reported with a difference of 2.6 mm (SD: 0.6 mm) in CAL gain between the best and the worst center. Sanz el al. 8 compared the use of EMD and membrane barrier (guided tissue regeneration [GTR]) in a 1-year randomized two-arm trial involving 75 patients at seven centers in three countries. Results at the 1-year follow-up demonstrated a mean CAL gain of 3.1 mm for the EMD and 2.5 mm for GTR-treated defects (P <0.05). A significant difference was found also in the incidence of complications (EMD 6% versus GTR 100%). Furthermore, the multivariate analysis confirmed the observation by Tonetti et al. 7 of a significant center effect (2.6 mm) on the treatment outcome.
The adjunctive use of EMD was also evaluated in recent systematic reviews including meta-analyses of randomized controlled trials. 3, 9, 10 Based on data from eight included studies, Esposito et al. 10 reported that the use of EMD provided an overall added mean CAL gain of 1.3 mm at sites with intrabony defects. Giannobile and Somerman 3 also found superiority for EMD compared to OFD. Further, the magnitude of enhanced CAL gain following the use of EMD that was reported in these reviews was comparable to that found for GTR (1.1 mm) in recent systematic reviews. 5, 11 Although these data may speak in favor of the adjunctive use of EMD in conjunction with surgical treatment of angular bone defects, to our knowledge, available data with regard to the long-term stability of the regained clinical attachment are limited. In an earlier publication, 12 we reported the 1-year followup data from a case series of 108 consecutively treated periodontal patients (145 EMD-treated intrabony defects). The included patient sample demonstrated a mean CAL gain of 4.6 mm, a mean probing depth (PD) reduction of 5.2 mm, and a mean gingival recession of 0.6 mm at 1 year. The radiographic defect depth (RDD) was reduced by 2.9 mm and the defect width by 1.9 mm. The aim of the present report was to analyze the long-term (5 years) stability of CAL gains following the use of EMD in the treatment of intrabony defects.
MATERIALS AND METHODS

Sample
The patient sample included in the present report derived from the total pool of patients at the Department of Periodontology, Public Dental Service, Karlstad, Sweden that had been treated with regenerative periodontal surgery using EMD during the period of 1995 to 1997. The population comprised 125 consecutively treated patients, out of whom 114 had been treated for angular bone defects (146 defects) and 11 patients for lesions associated with furcation involvements. All patients provided informed consent to participate in the planned follow-up study. At the time of the retrieval of data for the present 5-year follow-up analysis of the treatment of angular defects (2002), 82 (72%) patients (age range: 18 to 77 years; 45 females and 37 males) with a total of 102 defects had complete data files, whereas 32 patients (44 defects) had been lost to the 5-year reexamination. The study was conducted in accordance with the Helsinki Declaration of 1975, as revised in 2000.
Treatment Protocol
Patients first received non-surgical periodontal therapy, which included oral hygiene instruction, plaque control monitoring, and scaling and root planing (SRP). The subgingival instrumentation, which required several sessions, was performed by a periodontist or a specially trained dental hygienist and included all parts of the dentition. Baseline examination. At least 6 months after completion of the basic treatment for the establishment of infection control, a full-mouth reexamination was performed (baseline examination). Based on the following inclusion criteria, each subject presented with at least one deep intrabony defect that qualified for regenerative periodontal surgery: 1) PD ‡5 mm from the gingival margin, 2) CAL ‡6 mm from the cementoenamel junction (CEJ), and 3) radiographic evidence of a proximal bone defect with a ‡3-mm intrabony component. All probing assessments were performed with the use of a calibrated manual periodontal probe ‡ (0.48-mm tip diameter), to the nearest millimeter at both the buccal and lingual aspects of the interdental site. In addition, the examination included assessment of marginal soft tissue recession (REC) from the CEJ and dichotomous local plaque score and bleeding on probing (BOP) score (within 15 seconds after pocket probing). Double recordings of PD and CAL performed on a subsample of subjects revealed that the intraexaminer reproducibility within a difference of -1 mm was 94% for PD and 90% for CAL.
Regenerative periodontal therapy. Immediately before the surgical treatment, the patients rinsed the mouth with a 0.2% chlorhexidine solution for 90 seconds. The area subjected to surgery was anaesthetized with lidocaine, § and following intrasulcular and, if necessary, releasing incisions, buccal and lingual full-thickness flaps were elevated and the epithelium was removed from the inside of the flaps. Granulation tissue residing in the defect area was carefully excised and the root surface scaled and planed. No bone recontouring was performed.
Following the debridement of the site, assessments were carried out with respect to 1) position of the bone crest (BC) in relation to CEJ (distance CEJ-BC), 2) position of the bottom of the bony defect in relation to CEJ (distance CEJ-BoBD), and 3) depth of the intrabony component of the periodontal defect (INTRA; distance BC-BoBD). The bone defect was also classified according to the predominating number of lining bone walls (1-, 2-, or 3-wall defect).
A gel containing 24% EDTA k was applied on the exposed portion of the root to remove the smear layer. The gel was kept in place for 2 minutes, after which the surgical area was rinsed with saline. Subsequently, the EMD preparation ¶ (enamel matrix proteins in a propylene glycol alginate vehicle) was applied to the root surface and adjacent defect space. Flaps were replaced and closed with single sutures. # ** Sutures were removed 1 to 2 weeks after surgery. Systemic antibiotic therapy (doxycycline, amoxicillin, or metronidazole for 10 days) was prescribed as a routine treatment in conjunction with the surgical treatment for patients treated during the first 2 years (63% of the total sample), whereas no antibiotics were used for the subsequently treated patients.
Post-surgical care. All patients were instructed to rinse the mouth twice daily with a 0.1% solution of chlorhexidine digluconate for 1 to 2 minutes. Selfperformed mechanical cleaning of the surgical site was reinstituted 4 to 6 weeks postoperatively. Professional tooth cleaning was performed once every 2 to 4 months during the first year. Subsequently, recalls for supportive periodontal therapy were scheduled every 3 to 6 months at the specialist or the referring clinic. No deep subgingival instrumentation of the treated sites was carried out during the first year of followup. Reexamination of the experimental sites was scheduled 1 and 5 years after regenerative therapy.
Radiographs. Periapical radiographs were obtained by the use of a long-cone parallel technique at baseline and 1 and 5 years. In the radiographs, the following distances were measured to the closest 0.5 mm using a transparent ruler and a magnifying lens (·2.5): 1) RDD, i.e., the vertical distance between the BC and the most coronal level along the root surface at which the periodontal ligament space was considered as having a normal width, 2) radiographic defect width (RDW), i.e., the perpendicular distance between the root surface and the lateral wall of the bone defect at the level of the BC.
The intraexaminer reproducibility was determined by repeated assessments with a 1-week interval of all the radiographs obtained from 10 randomly selected subjects. The standard deviation for repeated assessments was 0.47. Of the total number of measurements, 90% were reproduced within a difference of -0.5 mm.
Data Analysis
For the data analysis with respect to clinical probing assessments, the buccal or lingual site data that showed the greatest CAL value at baseline were selected for all time intervals. For each variable and examination interval, mean values and standard deviations were calculated. Changes over time in clinical and radiographic assessments were expressed in mean values and 95% confidence intervals (CIs). Primary efficacy variables were considered to be changes in PD, CAL, REC, and RDD.
The distribution of continuous variables was initially analyzed with the Kolmogorov-Smirnov test. Alterations in the various variables over time were statistically analyzed using the Student t test for paired comparison. An a error <0.05 was accepted for statistical significance. A stepwise regression model was employed for the analysis of factors influencing the outcome variable CAL change between the 1-and 5-year reexaminations. The model included both quantitative variables and qualitative (dummy) variables. The F value for a factor to be entered into the model was set at 4. All data analysis was performed with the use of a statistical program. † †
RESULTS
Analysis of Subjects and Teeth Lost to the 5-Year
Follow-Up Out of the 114 qualified patients for the 5-year followup, 32 (28%) had been lost after the 1-year posttreatment reexamination. Reasons for the loss of subjects were: deceased (nine patients), moved from the area (five), serious illness (two), extraction of the treated tooth (10) , reentry surgery at 3 years for photo documentation (one), unwilling to attend the 5-year follow-up examination (three), and unknown reasons (two). Sixteen (11%) of the 146 treated teeth had been extracted after the 1-year follow-up examination.
Comparison of the baseline characteristics between the examined 5-year sample and the group of dropout patients revealed no pertinent differences (Table 1) . Furthermore, no statistically significant differences were found between the two groups at the 1-year follow-up examination regarding clinical and radiographic outcome variables (Table 1) .
A separate analysis was carried out for the 16 teeth (10 patients) in the dropout group that had been extracted after the 1-year follow-up examination. This analysis did not reveal any statistically significant differences in primary outcome variables at 1 year for the extracted teeth compared to the rest of the sample.
Baseline Defect Characteristics
A total of 102 proximal intrabony defects in 82 patients were included in the present 5-year analysis. Since an analysis of potential interaction between subject or adjunctive use of antibiotics and CAL change following treatment revealed no statistically significant interaction, the data analysis in this report was based on the site level.
About 70% of the 102 defects were located in the maxilla (Table 1) . Two-wall defects were predominant (56%), and few 3-wall defects (6%) were included. Out of the treated defects, 53% were present in the incisor/ canine segment of the dentition, 37% in the premolar, and 10% in the molar regions.
One-and 5-Year Outcomes
At the 1-year follow-up examination, 10% of the 102 treated teeth showed presence of visible plaque and 19% gingivitis (BOP), while at 5 years, 24% of the teeth harbored plaque and 31% scored positive for BOP.
The overall therapeutic response is presented in Table 2 . At 1 year post-treatment, there was a mean PD reduction of 4.9 mm (P <0.001) and a corresponding mean CAL gain of 4.3 mm (P <0.001). The REC at the 1-year examination interval amounted to, on average, 0.6 mm (P <0.001). At the 5-year follow-up, a further mean PD reduction of 0.3 mm (P >0.05), CAL gain of 1.1 mm (P = 0.002), and reduction in recession of 0.8 mm (P = 0.005) had taken place.
Radiographic assessments at 1 year revealed that the bone defect had been reduced 2.9 mm in depth (P <0.001), on average, and 1.2 mm in width (P <0.001), i.e., the reduction of the presurgical defect depth amounted to 54% (Table 2) . At 5 years, the defect resolution compared to baseline was 61% (3.3 mm; P <0.001). Alterations in defect depth and width observed between 1 and 5 years of follow-up were not statistically significant (Table 2 ). In Figure 1 , some cases are presented (baseline and 1 and 5 years) to illustrate magnitudes of radiographic bone alterations observed.
The variability in the change of CAL and RDD between baseline and 1 and 5 years is illustrated in Table 3 , in which the outcome data are stratified according to the magnitude of change. A CAL gain ‡4 mm was recorded at a relative frequency of 63% and 65% at 1 and 5 years, respectively. Between 1 and 5 years the proportion of defects demonstrating a CAL gain ‡6 mm increased from 24% to 46%. Further loss of attachment compared to baseline was found for 1% of the treated defects at 1 year and 3% at 5 years. A similar description of the RDD changes revealed that 32% of the defects demonstrated a depth reduction ‡4 mm at 1 year compared to 40% at 5 years. Between 1 and 5 years, the percent of defects with ‡6 mm of reduction increased from 9% to 22%. Further loss of bone height, compared to pretreatment status, was recorded in 2% of the defects at 1 year, while the corresponding figure had increased to 11% at 5 years. Among the type 2-and 3-wall bone defects, 67% demonstrated a CAL gain ‡4 mm at the 1-and 5-year reexaminations, whereas in 1-wall defects, the corresponding figure was 56% and 64%, respectively. The defect site with loss of clinical attachment at 1 year belonged to the 1-wall category, and the two additional sites demonstrating attachment loss at 5 years were of type 2-or 3-wall defects.
The stepwise regression analysis revealed that degree of REC (coefficient -1.03; F = 51.0) and residual PD (coefficient 1.29; F = 34.5) at 1 year were significant predictors of CAL change during the 1-to 5-year interval. Thus, the greater the PD at 1 year, the greater was the CAL gain between 1 and 5 years, while an increased REC value at 1 year had the opposite effect. Characteristics such as 1) residual depth of the intrabony defect at 1 year, 2) bone defect category, and 3) smoking habits did not reach the defined F value for entrance into the model. The regression model was Radiographic illustrations of four cases before treatment (baseline) and at the 1-and 5-year follow-up examination. Case A) A man, 57 years old, and a non-smoker: mandibular left canine with a 2-wall defect. Baseline CAL = 11 mm. CAL gain = 9 mm at 1 and 5 years. Case B) A woman, 58 years old, and a non-smoker: maxillary right canine with a 1-and 2-wall defect. Baseline CAL = 13 mm. CAL gain = 7 mm at 1 year and 6 mm at 5 years. Case C) A woman, 62 years old, and a non-smoker: maxillary left second premolar with a 2-wall defect. Baseline CAL = 11 mm (mesial and distal) and 12 mm (palatal). CAL gain = 6 mm at 1 year and 5 mm at 5 years. Case D) A woman, 58 years old, and a non-smoker: mandibular right first molar with a 2-wall defect. Baseline CAL = 10 mm. CAL gain = 6 mm at 1 year and 5 mm at 5 years.
significant (P <0.0001) and explained 49% of the variance in CAL change in 1 to 5 years.
DISCUSSION
The present long-term follow-up study of regenerative therapy with EMD at tooth sites with angular bone defects demonstrated that the healing results obtained at 1 year post-treatment were essentially maintained over 5 years, but also that an additional regain of soft tissue height was evident accompanied by additional gain in CAL. Five years after the regenerative therapy, 65% of all sites exhibited a clinical attachment gain of ‡4 mm. A problem experienced in prospective clinical trials is the loss of subjects to follow-up examinations. In the present study, 72% of initially treated patients could be reexamined after 5 years. Comparison between retained and lost to follow-up subjects revealed, however, no significant differences in pertinent baseline characteristics or in treatment outcome variables at 1 year (Table 1) . Hence, it is not likely that the patients lost to follow-up would have had a significant effect on the interpretation of the 5-year outcome data reported in this article.
The evaluation of the efficacy of a treatment procedure ought to be based on patient-centered outcomes, e.g., satisfaction with regard to chewing comfort and esthetics. In this respect, tooth loss is a definitive treatment failure. Hence, applying the criteria of tooth survival as a true endpoint for treatment success in the current study, the 5-year success rate of the regenerative periodontal therapy with EMD was 89%. However, this figure may not properly describe the true outcome because other reasons than treatment failure might have underlain the decision for tooth extraction. The retrieval of information regarding the reasons underlying the general practitioners' decisions for tooth extraction revealed that most teeth had been extracted in conjunction with prosthetic/implant therapy involving the jaw segment of the EMD-treated tooth. Consequently, it cannot be ruled out that the compromised periodontal conditions per se, rather than failure of the regenerative therapy, may have contributed to the decision for tooth extraction. In fact, analyzing the pretreatment (baseline) periodontal conditions of the teeth lost during the interval of 1 to 5 years, it was evident that these teeth had severe loss of periodontal support (mean attachment loss ;10 mm) but not so different from the mean loss scored in the total sample. Further, the healing outcome at the 1-year follow-up was not significantly different from that of the teeth remaining in function at 5 years. Whatever the reason for tooth extraction, it is not feasible to judge whether the 5-year tooth survival rate may indicate an enhanced outcome since, to our knowledge, there are almost no such data available in the literature for conventional treatment procedures in cases with a comparable degree of periodontal destruction. McGuire and Nunn 13 retrospectively analyzed factors influencing tooth survival among 100 treated periodontal patients with at least 5 years of regular maintenance care (every 2 to 3 months) and found markedly reduced survival rates with increasing degree of bone loss; teeth with 75% bone loss showed a survival rate of ;70%. In another retrospective study, the tooth survival rate following regenerative therapy with GTR for teeth with an initial mean attachment loss of ;10 mm was calculated to be 96% after 10 years. 14 Taking into consideration surrogate outcome variables, the current 5-year data revealed further improvements compared to 1 year post-treatment. Thus, between 1 to 5 years postoperatively, a decrease in gingival recession of, on average, 0.8 mm, and a gain in CAL of 1.1 mm had taken place, whereas no significant alterations were observed with regard to PD or dimensions of the bone defect. These findings indicate that the improved CAL was an effect of alterations within the soft tissues, rather than within the hard tissue portion of the original defect and that it may take longer than 1 year to establish proper soft tissue topography at the site of surgical intervention. Such an interpretation is also supported by the regression analysis which disclosed that less REC during the first postoperative year and increased residual PD at the 1-year follow-up examination were significant, positive predictors of further gain in CAL.
The 5-year post-treatment data showed that 65% of the treated defects demonstrated a CAL gain of ‡4 mm, whereas 3% showed loss compared to the pretreatment status. With regard to the RDD, 40% of the sites revealed a bone gain of ‡4 mm at 5 years, and 11% presented with a bone loss varying from 1 to 6 mm. Only a few studies have reported clinical and/or radiographic outcome data beyond 1 year of follow-up after regenerative therapy with EMD in intrabony defects. Francetti et al., 15 in a 2-year follow-up study of 12 patients, and Parodi et al., 16 in a 3-year study involving 16 patients, did not observe any significant alterations in CAL compared to the outcome at 1 year. Heijl et al. 6 found no further change in CAL between 8 months and 3 years of follow-up in a study of 27 patients, but a significantly improved bone height. A recent 5-year report involving 11 cases showed a slight reduction (0.5 mm) of the CAL gain obtained at 1-year posttreatment, which the authors attributed to failure in maintaining adequate oral hygiene. 17 To conclude, short-term clinical results following regenerative therapy with EMD seem to be maintainable over periods of at least 3 to 5 years provided that adequate maintenance care is given.
The current results failed to demonstrate that smoking had an effect on the change in CAL during the late phase of follow-up (1 to 5 years). However, as reported by Heden et al., 12 smoking was identified to negatively influence the CAL change at 1 year posttreatment. Taken together, these findings indicate that smoking may mainly possess a negative effect during initial phase of wound healing, but does not influence the long-term stability of regained periodontal support.
CONCLUSION
Results of the present 5-year case series report demonstrated long-term stability of CAL gains at sites with deep intrabony defects after reconstructive surgery including application of enamel matrix proteins.
